GoodRx Holdings, Inc.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
| Year Ended December 31, | |||
|---|---|---|---|
| (in thousands) | 2025 | 2024 | 2023 |
| Cash flows from operating activities | |||
| Net income (loss) | $30,439 | $16,390 | $(8,868) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||
| Depreciation and amortization | 85,218 | 69,538 | 107,668 |
| Loss on extinguishment of debt | — | 2,077 | — |
| Amortization of debt issuance costs and discounts | 1,768 | 2,497 | 3,382 |
| Non-cash operating lease expense | 4,007 | 4,184 | 4,104 |
| Stock-based compensation expense | 76,626 | 99,026 | 104,820 |
| Deferred income taxes | 20,071 | (11,914) | (65,562) |
| Loss on operating lease assets | 4,409 | — | 1,353 |
| Loss on disposal of capitalized software | — | — | 7,975 |
| Loss on minority equity interest investment | — | — | 4,008 |
| Other | 1,810 | — | 1,348 |
| Changes in operating assets and liabilities, net of effects of business acquisitions: | |||
| Accounts receivable | (88,016) | (2,326) | (26,467) |
| Prescription reimbursement assets | (75,387) | (7,463) | (15,481) |
| Prepaid expenses and other assets | (8,387) | 13,790 | (16,681) |
| Accounts payable | 4,103 | (15,819) | 12,034 |
| Prescription reimbursement liabilities | 114,341 | 10,376 | 5,422 |
| Accrued expenses and other current liabilities | 1,185 | 9,911 | 21,253 |
| Operating lease liabilities | (6,269) | (4,953) | (2,930) |
| Other liabilities | 1,986 | (1,422) | 914 |
| Net cash provided by operating activities | 167,904 | 183,892 | 138,292 |
| Cash flows from investing activities | |||
| Purchase of property and equipment | (3,521) | (1,240) | (1,043) |
| Acquisitions | (43,440) | — | — |
| Capitalized software | (70,499) | (69,107) | (54,723) |
| Other | (2,500) | — | — |
| Net cash used in investing activities | (119,960) | (70,347) | (55,766) |
| Cash flows from financing activities | |||
| Proceeds from long-term debt | — | 472,033 | — |
| Payments on long-term debt | (5,000) | (639,038) | (5,271) |
| Payments of debt issuance costs | — | (2,673) | — |
| Repurchases of Class A common stock (1) | (216,372) | (158,845) | (103,974) |
| Proceeds from exercise of stock options | 61 | 19,046 | 5,941 |
| Employee taxes paid related to net share settlement of equity awards | (14,467) | (29,784) | (65,481) |
| Proceeds from employee stock purchase plan | 1,308 | 1,766 | 1,390 |
| Net cash used in financing activities | (234,470) | (337,495) | (167,395) |
| Net change in cash and cash equivalents | (186,526) | (223,950) | (84,869) |
| Cash and cash equivalents | |||
| Beginning of period | 448,346 | 672,296 | 757,165 |
| End of period | $261,820 | $448,346 | $672,296 |
| Supplemental disclosure of cash flow information | |||
| Income taxes paid, net of refunds received | $13,127 | $23,623 | $17,243 |
|---|---|---|---|
| Interest paid | 40,837 | 55,099 | 48,799 |
| Non cash investing and financing activities: | |||
| Right-of-use assets obtained in exchange for operating lease liabilities | 9,183 | 2,049 | 52 |
| Stock-based compensation included in capitalized software | 15,074 | 16,124 | 13,144 |
| Capitalized software included in accounts payable and accrued expenses and other current liabilities | 7,712 | 8,118 | 7,826 |
| Capitalized software transferred from prepaid assets | — | — | 5,751 |
(1)Repurchases of Class A common stock for the years ended December 31, 2025,2024, and 2023 include 20.0
million,20.9 million, and 12.0 million shares repurchased from related parties (after giving effect to the automatic
conversion of Class B common stock to Class A common stock upon such repurchase) for an aggregate
consideration of$84.9 million,$151.4 million, and$65.9 million, respectively. See "Note 14. Stockholders' Equity"
for additional information.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.